Skip to content

Clinical trials

Intracranial Aneurysm trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intracranial Aneurysm Country / region: United States Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20061
20074
20085
20095
20104
20112
20129
201310
20148
20158
20164
20171
20183
20194
20208
20215
20224
20237
20244
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Recruiting13
Terminated13
Active, not recruiting11
Withdrawn9
Unknown status8
Not yet recruiting4
Suspended3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medtronic Neurovascular Clinical Affairs10
Microvention-Terumo, Inc.7
Stryker Neurovascular6
Penumbra Inc.5
Centre hospitalier de l'Université de Montréal (CHUM)4
Medical University of South Carolina3
Montefiore Medical Center3
Northwestern University3
Cerus Endovascular, Inc.2
Henry Ford Health System2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intracranial Aneurysm111
Aneurysm26
Subarachnoid Hemorrhage17
Stroke8
Vasospasm, Intracranial6
Brain Neoplasms5
Vascular Diseases5
Arteriovenous Malformations4
Brain Diseases4
Cardiovascular Diseases4

Trials

Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.